The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Prorenata Biotech
Gold Coast City, Australia
A
1-10 Employees
2021
Key takeaway
Prorenata Biotech specializes in lipid nanoparticles and genetic medicine, focusing on advancing nanomedicine through innovative approaches like CRISPR. Their mission is to accelerate the development of gene-based therapeutics and vaccines, making them accessible to researchers and healthcare providers.
Reference
Core business
Nanomedicine - LNPs & Genetic Medicine - Prorenata Biotech
We are experts in Lipid Nanoparticles and Gene Editing using CRISPR. We will ensure your molecule reaches its full potential!
Medlab Clinical
Sydney, Australia
A
11-50 Employees
2012
Key takeaway
Medlab Clinical is an Australian biotechnology company that specializes in NanoCelle® drug delivery technology, which has potential applications in nanomedicine. This innovative approach aims to enhance the effectiveness of existing and new pharmaceuticals, particularly for patients with chronic diseases and mental health conditions.
Reference
Product
Medlab - NanoCelle®
Medlab NanoCelle® is next generation drug delivery with potential medical and international applications such as small and large molecules.
NanoCube
Melbourne, Australia
A
1-10 Employees
2021
Key takeaway
NanoCube and its spin-off, NanoCube Health, focus on innovative research and development in nanotechnology, particularly in healthcare. Their work highlights the potential applications of nanomedicine, leveraging advanced materials and artificial intelligence to enhance medical practices.
Reference
Core business
Home
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Brandon Capital Partners
Melbourne, Australia
A
11-50 Employees
2006
Key takeaway
The company is dedicated to addressing neurodegenerative diseases, particularly dementia, through innovative therapies. Their focus on improving physiological processes aligns with advancements in nanomedicine for targeted treatment strategies.
Reference
Product
George Medicines - Brandon Capital
Medicision Pty. Ltd.
Sydney, Australia
A
11-50 Employees
2018
Key takeaway
Medicision focuses on enhancing health and wellbeing through innovative healthcare solutions and partnerships with leading industry providers. They emphasize personalized approaches to treatment, including advancements in precision medicine.
Reference
Core business
Medicision: Precision Healthcare Worldwide
Precision Medicine Worldwide
EnGeneIC
Sydney, Australia
A
11-50 Employees
2000
Key takeaway
EnGeneIC is a clinical-stage biopharmaceutical company that specializes in nanomedicine through its proprietary EDV™ nanocell platform, which targets the delivery of chemotherapeutics and functional nucleic acids in cancer treatment. Their innovative approach enhances the potency of existing therapies while reducing toxicity and stimulating an anti-tumor immune response.
Reference
Product
Technology - EnGeneIC
TechnologyEnGeneIC is a clinical stage biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform that enables current cancer treatments to be more potent and far less toxic, while also stimulating a potent anti-tumor immune response.EDV … Continue reading →
Applied Precision Medicine Pty Ltd
Melbourne, Australia
A
1-10 Employees
2012
Key takeaway
Applied Precision Medicine focuses on personalized medicine, which is closely related to advancements in nanomedicine, ultimately aiming to improve the quality of life and healthcare through precision diagnostics.
Reference
Core business
Personalised Medicine | Applied Precision Medicine
Applied Precision Medicine means better quality of life and healthcare.
The Nanomaterials for Biology Group
Melbourne, Australia
A
- Employees
-
Key takeaway
The company's research focuses on enhancing drug and vaccine delivery through the use of nanomaterials, specifically developing nanomedicines for vaccination and cancer therapy.
Reference
Core business
NanoMaterials for Biology
Our research seeks to improve drug delivery by understanding how nanomaterials interact with cells. We make nanomedicines for vaccination and cancer therapy
Nexomics
Melbourne, Australia
A
11-50 Employees
2014
Key takeaway
Nexomics is a specialized contract service provider that offers advanced oncology laboratory assays and high complexity genomic tests, which are crucial for cancer diagnostics and research. Their expertise in supporting clinical trials positions them as a key partner in the evolving landscape of cancer testing.
Reference
Core business
Home - Nexomics
Navi Medical Technologies
Melbourne, Australia
A
11-50 Employees
2017
Key takeaway
Navi Medical Technologies is dedicated to addressing unmet clinical needs through innovative products that improve pediatric healthcare. Their focus on developing solutions, such as the Neonav® system, aims to enhance the delivery of lifesaving therapies for critically ill newborns and children.
Reference
Product
Our Products — Navi Medical Technologies
Technologies which have been searched by others and may be interesting for you:
When exploring the Nanomedicine industry in Australia, several key considerations are crucial for making informed decisions. First, understanding the regulatory landscape is essential, as nanomedicine products must comply with strict guidelines set by agencies like the Therapeutic Goods Administration (TGA). This includes safety and efficacy evaluations that can be time-consuming and costly. Challenges often arise from the complexity of nanomaterials, requiring thorough characterization and risk assessment to ensure public health safety. Opportunities in the Australian market are significant, driven by strong research institutions and collaborations between academia and industry. This provides a fertile ground for innovation and development of novel therapies. However, environmental concerns related to the production and disposal of nanomaterials must be addressed to ensure sustainable practices. The competitive landscape is evolving, with both established companies and startups vying for market share. Staying informed about trends and advancements in technology is vital for identifying potential partners or competitors. Furthermore, the global market relevance of Australian nanomedicine is increasing, thanks to initiatives aimed at exporting research findings and products, which positions Australia as a significant player in the international nanomedicine arena. Overall, thorough research into these aspects will aid in navigating the complexities of the nanomedicine sector in Australia.
Some interesting numbers and facts about your company results for Nanomedicine
Country with most fitting companies | Australia |
Amount of fitting manufacturers | 261 |
Amount of suitable service providers | 210 |
Average amount of employees | 11-50 |
Oldest suiting company | 2000 |
Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Nanomedicine
What are related technologies to Nanomedicine?
Based on our calculations related technologies to Nanomedicine are Glass, Superconductors, High-Performance Materials, Raw Materials, Phase Change Materials
Who are Start-Ups in the field of Nanomedicine?
Start-Ups who are working in Nanomedicine are Prorenata Biotech, NanoCube
Which industries are mostly working on Nanomedicine?
The most represented industries which are working in Nanomedicine are Healthcare, Medical, Other, Biotechnology, Pharmaceuticals
How does ensun find these Nanomedicine Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.